ProCAncer-I at the European Congress of Radiology 2023

Published on: March 8, 2023
Categories: News

The European Congress of Radiology 2023 took place in Vienna (01-05/03/2023), returning to its traditional spot as a spring meeting. The congress welcomed 17,262 participants from 122 countries. Under the watch of the magnificent golden skull which adorned the congress entrance hall, medical imaging professionals and industry leaders gathered for a meeting marked by cutting-edge science, invaluable education and unforgettable moments. Dr. Papanikolaou presented some early results of ProCAncer-I project regarding “AI modelling strategies with multi-centric data”.

 

Also, the Hacettepe University Hospital gave 3 presentations concerning the developments on monitoring prostate cancer patients, in which ProCAncer-I was also involved:  “Prediction of clinically significant prostate cancer using machine learning models”, “Single-center experience of multiparametric prostate MRI and PI-RADSv2: Exploring the learning curve” and “Long -term follow-uo results of multiparametric prostate MRI and prognostic value of PI-RADSv2″  by Ö. Önder, Y. Yaraşır, V. Gürler, M. Ayva, M. S. Yazici, B. Akdogan, M. Karçaaltincaba, M. N. Özmen, D. Akata.

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!